David Walterhouse

4.5k total citations
91 papers, 3.2k citations indexed

About

David Walterhouse is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, David Walterhouse has authored 91 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 39 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in David Walterhouse's work include Sarcoma Diagnosis and Treatment (42 papers), Hedgehog Signaling Pathway Studies (29 papers) and Tumors and Oncological Cases (19 papers). David Walterhouse is often cited by papers focused on Sarcoma Diagnosis and Treatment (42 papers), Hedgehog Signaling Pathway Studies (29 papers) and Tumors and Oncological Cases (19 papers). David Walterhouse collaborates with scholars based in United States, Italy and Denmark. David Walterhouse's co-authors include Philip M. Iannaccone, Elisabeth H. Villavicencio, Joon Won Yoon, William H. Meyer, Douglas S. Hawkins, James R. Anderson, David M. Parham, Marilyn Lamm, John C. Breneman and Jane L. Meza and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

David Walterhouse

87 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Walterhouse United States	33	1.7k	1.2k	678	622	599	91	3.2k
Yukichi Tanaka Japan	31	1.8k 1.1×	1.1k 0.9×	977 1.4×	1.1k 1.8×	466 0.8×	187	4.2k
Edwin C. Douglass United States	31	1.5k 0.9×	1.1k 0.9×	826 1.2×	518 0.8×	547 0.9×	70	3.3k
Maija Kiuru United States	26	1.6k 0.9×	870 0.7×	629 0.9×	414 0.7×	232 0.4×	90	3.1k
Katharina Biermann Netherlands	41	1.7k 1.0×	1.3k 1.1×	1.4k 2.0×	2.1k 3.4×	330 0.6×	121	4.8k
Kazuto Yamazaki Japan	31	916 0.5×	639 0.5×	710 1.0×	743 1.2×	385 0.6×	159	3.1k
Kenji Okami Japan	21	1.4k 0.8×	650 0.5×	850 1.3×	635 1.0×	299 0.5×	138	2.5k
Yukio Takeshima Japan	34	941 0.6×	1.4k 1.2×	773 1.1×	494 0.8×	263 0.4×	168	3.4k
Renata Boldrini Italy	35	1.5k 0.9×	583 0.5×	696 1.0×	904 1.5×	187 0.3×	175	3.8k
Fréderique Larousserie France	28	536 0.3×	1.3k 1.1×	627 0.9×	393 0.6×	426 0.7×	103	2.9k
E C Douglass United States	33	1.6k 1.0×	1.0k 0.9×	709 1.0×	386 0.6×	602 1.0×	51	3.3k

Countries citing papers authored by David Walterhouse

Since Specialization

Citations

This map shows the geographic impact of David Walterhouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Walterhouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Walterhouse more than expected).

Fields of papers citing papers by David Walterhouse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Walterhouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Walterhouse. The network helps show where David Walterhouse may publish in the future.

Co-authorship network of co-authors of David Walterhouse

This figure shows the co-authorship network connecting the top 25 collaborators of David Walterhouse. A scholar is included among the top collaborators of David Walterhouse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Walterhouse. David Walterhouse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geller, James I., Michael V. Ortiz, David Walterhouse, et al.. (2025). Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor. Pediatric Blood & Cancer. 72(10). e31915–e31915.

Walz, Amy L., et al.. (2025). Iohexol Clearance and Biomarker Analysis to Predict Toxicity in Patients With Acute Lymphoblastic Leukemia and Lymphoma Receiving High-dose Methotrexate. Journal of Pediatric Hematology/Oncology. 47(6). e235–e240.

Gupta, Abha A., Bhuvana A. Setty, Mary Frances Wedekind, et al.. (2024). Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatric Blood & Cancer. 72(3). e31477–e31477.

Sparber‐Sauer, Monika, Andrea Ferrari, Sheri L. Spunt, et al.. (2023). The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT). Cancer Medicine. 12(10). 11719–11730. 12 indexed citations

Xue, Wei, Ralph P. Ermoian, Julie A. Bradley, et al.. (2023). Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group. Cancer. 129(11). 1735–1743. 5 indexed citations

Crane, Jacquelyn, Wei Xue, Amira Qumseya, et al.. (2022). Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group. Pediatric Blood & Cancer. 69(6). e29644–e29644. 24 indexed citations

Ferrari, Andrea, Daniel Orbach, Monika Sparber‐Sauer, et al.. (2022). The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium. European Journal of Cancer. 169. 10–19. 19 indexed citations

Routh, Jonathan C., Roshni Dasgupta, Yueh‐Yun Chi, et al.. (2020). Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. International Journal of Cancer. 147(11). 3168–3176. 20 indexed citations

Rastatter, Jeffrey C., et al.. (2020). Survival of Patients With Non‐Rhabdomyosarcoma Soft Tissue Sarcomas of the Head and Neck. The Laryngoscope. 131(2). E500–E508. 5 indexed citations

10.

Everson, Joshua L., Joon Won Yoon, Elizabeth J. Leslie, et al.. (2017). Sonic Hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis. Development. 144(11). 2082–2091. 49 indexed citations

11.

Walterhouse, David, Alberto S. Pappo, Jane L. Meza, et al.. (2014). Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Journal of Clinical Oncology. 32(31). 3547–3552. 100 indexed citations

12.

Weiss, Aaron R., Elizabeth Lyden, James R. Anderson, et al.. (2013). Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma Committee. Journal of Clinical Oncology. 31(26). 3226–3232. 75 indexed citations

13.

Yoon, Joon Won, Marisa Gallant, Marilyn Lamm, et al.. (2013). Noncanonical Regulation of the Hedgehog Mediator GLI1 by c-MYC in Burkitt Lymphoma. Molecular Cancer Research. 11(6). 604–615. 44 indexed citations

14.

Mascarenhas, Leo, Elizabeth Lyden, Philip P. Breitfeld, et al.. (2010). Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 28(30). 4658–4663. 80 indexed citations

15.

Kent, Paul, Murad Alam, Amy S. Paller, et al.. (2009). GLI1 genotypes do not predict basal cell carcinoma risk: a case control study. Molecular Cancer. 8(1). 113–113. 2 indexed citations

16.

Burke, Michael J., David Walterhouse, David A. Jacobsohn, Reggie Duerst, & Morris Kletzel. (2007). Tandem high‐dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high‐risk Ewing family tumors. Pediatric Blood & Cancer. 49(2). 196–198. 21 indexed citations

17.

Walterhouse, David, Marilyn Lamm, Elisabeth H. Villavicencio, & Philip M. Iannaccone. (2003). Emerging Roles for Hedgehog-Patched-Gli Signal Transduction in Reproduction1. Biology of Reproduction. 69(1). 8–14. 51 indexed citations

18.

Lamm, Marilyn, Daniel Barnett, Christy M. Hebner, et al.. (2002). Sonic Hedgehog Activates Mesenchymal Gli1 Expression during Prostate Ductal Bud Formation. Developmental Biology. 249(2). 349–366. 133 indexed citations

19.

Yoon, Joon Won, Yasuhiro Kita, Daniel J. Frank, et al.. (2002). Gene Expression Profiling Leads to Identification of GLI1-binding Elements in Target Genes and a Role for Multiple Downstream Pathways in GLI1-induced Cell Transformation. Journal of Biological Chemistry. 277(7). 5548–5555. 265 indexed citations

20.

Villavicencio, Elisabeth H., David Walterhouse, & Philip M. Iannaccone. (2000). The Sonic Hedgehog–Patched–Gli Pathway in Human Development and Disease. The American Journal of Human Genetics. 67(5). 1047–1054. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact